The Joint cuts 2026 system-wide sales view to $508-512 million as comps fall 1.9%
GlobeNewswire · · AI-summarised by FinFlash
The Joint Corp. posted third-quarter revenue of Softer clinic sales point to pressure on small-cap consumer services. Steady EBITDA guidance and buybacks offer some support; watch comps. Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.So What?
Understand the context